Gene · 10155
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis. | Drug Resist Updat | 2026 | 42476098 | PubTator, text mining | PubMed |
| Pan-cancer proteogenomic interrogation of the ubiquitin-proteasome system. | Cell Death Differ | 2026 | 42472879 | PubTator, text mining | PubMed |
| Epigenetic Reactivation of Lineage Differentiation to Target Leukemia. | bioRxiv | 2026 | 42465368 | PubTator, text mining | PubMed |
| TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence. | Immunol Res | 2026 | 42377665 | PubTator, text mining | PubMed |
| Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors. | bioRxiv | 2026 | 42367935 | PubTator, text mining | PubMed |
| DHODH Drives Sunitinib Resistance Via a Non-Enzymatic Mechanism by Inhibiting TRIM28 Ubiquitination and Consequent VEGFA Activation in RCC. | Adv Sci (Weinh) | 2026 | 42335405 | PubTator, text mining | PubMed |
| Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma. | Front Cell Dev Biol | 2026 | 42326014 | PubTator, text mining | PubMed |
| Radiation-Induced Tumor-Intrinsic LTβR N-Glycosylation Suppresses Pyroptosis Through TRIM28-Mediated PCBP2 SUMOylation to Promote Gastric Cancer Radioresistance. | Adv Sci (Weinh) | 2026 | 42325190 | PubTator, text mining | PubMed |
| A TRIM28-MCM7 regulatory axis sustains DNA replication programs in glioblastoma. | Biochem Biophys Res Commun | 2026 | 42308765 | PubTator, text mining | PubMed |
| Shogaol triggers apoptosis and ferroptosis in Ewing sarcoma by targeting the polo-like kinase 1/nucleophosmin 1 axis. | Free Radic Biol Med | 2026 | 42303003 | PubTator, text mining | PubMed |
| TRIM17 downregulation modulates CRPC progression and enzalutamide resistance by derepressing BCL2 expression via the p53-dependent and p53-independent pathways. | Cell Death Differ | 2026 | 42288623 | PubTator, text mining | PubMed |
| Correction: KAP1-associated transcriptional inhibitory complex regulates C2C12 myoblasts differentiation and mitochondrial biogenesis via miR-133a repression. | Cell Death Dis | 2026 | 42276979 | PubTator, text mining | PubMed |
| Next generation technologies for CRISPR-based epigenome and transcriptional modulation. | Curr Opin Biomed Eng | 2026 | 42266835 | PubTator, text mining | PubMed |
| TIF1β Promotes Myocardial Ischemia-Reperfusion Injury by Stabilizing TRAF6 through Mediating TRAF6 SUMOylation. | Int Heart J | 2026 | 42219331 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor-18 (FGF-18) Attenuates ox-LDL-Induced Endothelial Inflammation and Monocyte Adhesion by Inhibiting TRIM28. | J Interferon Cytokine Res | 2026 | 42212430 | PubTator, text mining | PubMed |
| Transposable element small RNAs and large RNAs in aging brains and implications in Huntington's and Parkinson's disease. | Genome Res | 2026 | 42209156 | PubTator, text mining | PubMed |
| TIF1 Family Proteins as Modulators of Cell Death: Mechanisms and Therapeutic Opportunities. | Biomolecules | 2026 | 42194066 | PubTator, text mining | PubMed |
| ZNF184 negatively regulates HR repair and predicts poor prognosis in acute lymphoblastic leukemia. | Nucleic Acids Res | 2026 | 42165129 | PubTator, text mining | PubMed |
| Mechanisms coordinating exit from the stem cell state in mammals. | Genes Dev | 2026 | 42156139 | PubTator, text mining | PubMed |
| TRIM28-mediated SUMOylation of SREBF1 drives PD‑L1 N‑glycosylation and immune evasion in bladder cancer. | Cell Death Dis | 2026 | 42151123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10155/papers?page=2